Sexually transmitted
infections, including the human immunodeficiency
virus (HIV) and the human papillomavirus (HPV), disproportionally
impact those in low-resource settings. Early diagnosis is essential
for managing HIV. Similarly, HPV causes nearly all cases of cervical
cancer, the majority (90%) of which occur in low-resource settings.
Importantly, infection with HPV is six times more likely to progress
to cervical cancer in women who are HIV-positive. An inexpensive,
adaptable point-of-care test for viral infections would make screening
for these viruses more accessible to a broader set of the population.
Here, we report a novel, cost-effective electrochemical platform using
gold leaf electrodes to detect clinically relevant viral loads. We
have combined this platform with loop-mediated isothermal amplification
and a CRISPR-based recognition assay to detect HPV. Lower limits of
detection were demonstrated down to 10
4
total copies of
input nucleic acids, which is a clinically relevant viral load for
HPV DNA. Further, proof-of-concept experiments with cervical swab
samples, extracted using standard extraction protocols, demonstrated
that the strategy is extendable to complex human samples. This adaptable
technology could be applied to detect any viral infection rapidly
and cost-effectively.